Evidence map›Paper›PMID 42498993›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Hierarchical Ordering Decouples the SHG-Birefringence-LIDT Trade-Off in a Single-Phase Mid-Infrared Nonlinear Optical Crystal.

Yan Guo, Ming-Xin Li, Ying Guo, Bin-Wen Liu, Xiao-Ming Jiang, Guo-Cong Guo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yan GuoState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, P. R. China.
Ming-Xin LiState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, P. R. China.
Ying GuoState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, P. R. China.
Bin-Wen LiuState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, P. R. China.ORCID https://orcid.org/0000-0003-1061-1000
Xiao-Ming JiangState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, P. R. China.ORCID https://orcid.org/0000-0001-6837-4429
Guo-Cong GuoState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, P. R. China.ORCID https://orcid.org/0000-0002-7450-9702

Funding

National Natural Science Foundation of China 22175172Natural Science Foundation of Fujian Provinces 2024J010041Strategic Priority Research Program of the Chinese Academy of Sciences XDB1170000
6 · The paper itself

Abstract

The pursuit of high-performance infrared nonlinear optical crystals is perpetually constrained by the inherent trade-offs among second-harmonic generation (SHG) efficiency, laser-induced damage threshold (LIDT), and birefringence for phase-matching (PM). Traditional compositional engineering, which seeks new formulas, is fundamentally limited by a compound's intrinsic electronic structure. Here, we introduce a paradigm shift of performance optimization through hierarchical order editing within a fixed chemical composition. In the model compound [Hg

Indexed as

inorganic supramolecularnonlinear opticalsecond‐harmonic generationsuperstructuretwinning

Identifiers

PMID42498993
PMCPMC13548970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.